5//SEC Filing
KELLY MICHAEL /NMN/ 5
Accession 0001209191-05-009456
CIK 0000918066other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:35 PM ET
Size
16.3 KB
Accession
0001209191-05-009456
Insider Transaction Report
Form 5
KELLY MICHAEL /NMN/
VP, Commercial Operations
Transactions
- Other
Common Stock
2004-02-03$7.68/sh+136$1,044→ 3,977 total(indirect: 401 (k)) - Other
Common Stock
2004-03-03$7.28/sh+1,477$10,753→ 5,453 total(indirect: 401 (k)) - Other
Common Stock
2004-05-13$6.20/sh+504$3,125→ 5,957 total(indirect: 401 (k)) - Other
Common Stock
2004-06-30$4.04/sh+1,156$4,667→ 1,156 total - Other
Common Stock
2004-12-31$4.09/sh+4,112$16,814→ 5,268 total - Other
Common Stock
2004-01-22$8.49/sh+301$2,555→ 3,841 total(indirect: 401 (k))
Holdings
- 50,000
Stock Options(Right to buy)
Exercise: $4.97From: 2003-12-01Exp: 2012-12-01→ Common Stock (50,000 underlying) - 30,000
Stock Options(Right to buy)
Exercise: $7.94From: 2005-02-18Exp: 2014-02-18→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Shares acquired under Guilford's stock purchase plan.
- [F2]Shares issued to 401 (k) plan account of reporting person as part of company match program; amounts vest in participant accounts 25% per year based on years of service with company.
Documents
Issuer
GUILFORD PHARMACEUTICALS INC
CIK 0000918066
Entity typeother
Related Parties
1- filerCIK 0001236486
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:35 PM ET
- Size
- 16.3 KB